Hemosiderosis medical therapy

Jump to navigation Jump to search

Hemosiderosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemosiderosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemosiderosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemosiderosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemosiderosis medical therapy

CDC on Hemosiderosis medical therapy

Hemosiderosis medical therapy in the news

Blogs on Hemosiderosis medical therapy

Directions to Hospitals Treating Hemosiderosis

Risk calculators and risk factors for Hemosiderosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Medical Therapy

  • There is no treatment for IPH; the mainstay of therapy is supportive care based on the presentation and acute vs. chronic nature of the patient.
  • Blood transfusion should be done to correct severe anemia and shock during the acute phase.
  • Patients with acute IPH and respiratory failure secondary to alveolar hemorrhage may require invasive ventilation support. It is also recommended to consider immunosuppressive therapy in addition to high dose systemic corticosteroids in these patients.
  • Immuno-suppressants such as hydroxychloroquine, azathioprine, cyclophosphamide, and 6-mercaptopurine are sometimes used in combination with steroids for severe cases, or when steroids are contraindicated or not tolerated.
  • Other treatment options with unknown efficacies include intravenous immunoglobulin (IVIG), plasmapheresis, liposteroids, and dietary modification (gluten-free diet in those with celiac disease and IPH has been shown to improve symptoms).

References

Template:WH Template:WS